Results 51 to 60 of about 43,735 (192)

Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors. [PDF]

PLoS ONE, 2010
Histone deacetylase inhibitors (HDI) dampen cellular innate immune response by decreasing interferon production and have been shown to increase the growth of vesicular stomatitis virus and HSV.
Heather MacTavish, Jean-Simon Diallo, Baocheng Huang, Marianne Stanford, Fabrice Le Boeuf, Naomi De Silva, Julie Cox, John Graydon Simmons, Tanya Guimond, Theresa Falls, J Andrea McCart, Harry Atkins, Caroline Breitbach, David Kirn, Stephen Thorne, John C Bell   +15 more
doaj   +1 more source

Clinical and computed tomography findings of fatal poxviral vasculitis in a domestic shorthair cat

Veterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract This report describes the clinical presentation, haematological abnormalities and imaging findings of systemic poxvirus infection in a cat that resulted in widespread severe dermal oedema and systemic inflammatory response syndrome. The cat lacked cutaneous lesions before the onset of dermal oedema, but developed crusting skin lesions and a ...
Mica Taylor, Harriet R. Hall, Hannah Wong, Lorraine Peschard, Emanuele Ricci, Katie E. McCallum   +5 more
wiley   +1 more source

Ocular Vaccinia Infection in Dairy Worker, Brazil

Emerging Infectious Diseases, 2018
We studied a clinical case of vaccinia virus that caused an ocular manifestation in a dairy worker in Brazil. Biologic and molecular analyses identified a co-infection with 2 isolates from different Brazilian vaccinia virus phylogenetic groups.
Maurício Teixeira Lima, Graziele Pereira Oliveira, Felipe Lopes Assis, Danilo Bretas de Oliveira, Sidiner Mesquita Vaz, Giliane de Souza Trindade, Jônatas Santos Abrahão, Erna Geessien Kroon   +7 more
doaj   +1 more source

A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China. [PDF]

PLoS ONE, 2012
BACKGROUND: Pre-existing immunity to Vaccinia Tian Tan virus (VTT) resulting from a large vaccination campaign against smallpox prior to the early 1980s in China, has been a major issue for application of VTT-vector based vaccines.
Qiang Liu, Weijin Huang, Jianhui Nie, Rong Zhu, Dongying Gao, Aijing Song, Shufang Meng, Xuemei Xu, Youchun Wang   +8 more
doaj   +1 more source

Enhancing Oncolytic Adenovirus Replication by Early Region 1A Protein‐Mediated Degradation of E1A Binding Protein p300

MedComm, Volume 7, Issue 4, April 2026.
E1A is an important protein for adenovirus to initiate viral replication. Previous reports have shown that E1A binds to p300 as a regulatory factor. However, our study provides a new perspective that E1A promotes oncolytic adenovirus replication by degrading p300.
Boduan Xiao, Qingzhe Yang, Shichuan Hu, Jianchuan Hu, Zhongbing Qi, Yao Zhang, Yu Qin, Ping Cheng   +7 more
wiley   +1 more source

Compact, Synthetic, Vaccinia Virus Early/Late Promoter for Protein Expression

BioTechniques, 1997
Vaccinia virus, a member of the poxvirus family, is widely used as a mammalian cell expression vector. Vaccinia virus replicates in the cytoplasm and has its own transcriptional system, making it necessary to use viral promoters.
Sekhar Chakrabarti, Jerry R. Sisler, Bernard Moss   +2 more
doaj   +1 more source

Allergic airway disease in mice alters T and B cell responses during an acute respiratory poxvirus infection. [PDF]

PLoS ONE, 2013
Pulmonary viral infections can exacerbate or trigger the development of allergic airway diseases via multiple mechanisms depending upon the infectious agent.
Crystal C Walline, Sarita Sehra, Amanda J Fisher, Lynette M Guindon, Ian M Kratzke, Jessica B Montgomery, Kelsey P Lipking, Nicole L Glosson, Heather L Benson, George E Sandusky, David S Wilkes, Randy R Brutkiewicz, Mark H Kaplan, Janice S Blum   +13 more
doaj   +1 more source

Vaccines at the Heart of Hepatitis Elimination: Insights From the ESCMID Study Group for Viral Hepatitis (ESGVH)

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT The global elimination of viral hepatitis by 2030 remains an ambitious goal that hinges not only on diagnostics and therapeutics but fundamentally on the strategic use and continued innovation of vaccines. The ESCMID Study Group for Viral Hepatitis (ESGVH) convened to examine the role of vaccination as the cornerstone of hepatitis prevention ...
Oana Săndulescu, Gülşen Özkaya Şahin, Susanne Gjeruldsen Dudman, Zeinab Nabil Ahmed Said, Mario U. Mondelli, on behalf of ESCMID Study Group for Viral Hepatitis (ESGVH)   +5 more
wiley   +1 more source

Susceptibility of different leukocyte cell types to Vaccinia virus infection

Virology Journal, 2004
Background Vaccinia virus, the prototype member of the family Poxviridae, was used extensively in the past as the Smallpox vaccine, and is currently considered as a candidate vector for new recombinant vaccines.
Sánchez-Puig Juana M, Sánchez Laura, Roy Garbiñe, Blasco Rafael   +3 more
doaj   +1 more source

CD20+FCRL4+ B Cells Activate CD8+ T Cells via MHC‐I Restriction in Nasopharyngeal Carcinoma Anti‐Tumor Immunity

Advanced Science, Volume 13, Issue 13, 3 March 2026.
CD20⁺FCRL4⁺ B cells in nasopharyngeal carcinoma actively cross‐present exogenous tumor antigens via MHC‐I, enhancing CD8⁺ T‐cell activation, memory formation, and cytotoxicity. IFNγ‐driven WDFY4 upregulation facilitates this process. These findings reveal an unconventional B‐cell–mediated antitumor mechanism and indicate potential relevance to ...
Benjian Zhang, Xiaotian Yuan, Kelei Gao, Bo You, Yaxuan Wang, Lai Meng, Zirong Chen, Shaobing Xie, Yunqing Liu, Zijian Dong, Shumin Xie, Ruohao Fan, Fengjun Wang, Junyi Zhang, Zhihai Xie, Yongzhen Mo, Hua Zhang, Weihong Jiang   +17 more
wiley   +1 more source